Kezar Life Sciences, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Kezar Life Sciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2017 to Q3 2024.
  • Kezar Life Sciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$20.3M, a 12.1% increase year-over-year.
  • Kezar Life Sciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$95.8M, a 9.1% decline year-over-year.
  • Kezar Life Sciences, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$102M, a 49.3% decline from 2022.
  • Kezar Life Sciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$68.2M, a 24.9% decline from 2021.
  • Kezar Life Sciences, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$54.6M, a 30.9% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$95.8M -$20.3M +$2.79M +12.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$98.6M -$21.5M +$2.76M +11.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-12
Q1 2024 -$101M -$21.7M +$541K +2.44% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-12
Q4 2023 -$102M -$32.3M -$14.1M -77.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 -$87.8M -$23.1M -$5.26M -29.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$82.5M -$24.3M -$8.12M -50.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-12
Q1 2023 -$74.4M -$22.2M -$6.18M -38.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-12
Q4 2022 -$68.2M -$18.2M -$3.97M -27.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 -$64.3M -$17.8M -$3.39M -23.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$60.9M -$16.2M -$3.23M -24.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-13
Q1 2022 -$57.7M -$16M -$3.03M -23.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-13
Q4 2021 -$54.6M -$14.2M -$3.27M -29.9% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-14
Q3 2021 -$51.4M -$14.5M -$3.17M -28.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$48.2M -$13M -$3.46M -36.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 -$44.7M -$13M -$2.98M -29.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-10
Q4 2020 -$41.7M -$10.9M -$1.36M -14.2% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-11
Q3 2020 -$40.4M -$11.3M -$2.14M -23.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$38.2M -$9.5M -$782K -8.97% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-09
Q1 2020 -$37.5M -$10M -$2.37M -31% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-09
Q4 2019 -$35.1M -$9.58M -$3.8M -65.7% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 -$31.3M -$9.15M -$3.49M -61.5% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-11
Q2 2019 -$27.8M -$8.72M -$1.94M -28.7% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-11
Q1 2019 -$25.9M -$7.64M -$2.7M -54.5% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-11
Q4 2018 -$23.2M -$5.78M -$3.48M -151% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 -$19.7M -$5.66M -$3.58M -172% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-12
Q2 2018 -$16.1M -$6.78M -$4.9M -260% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-12
Q1 2018 -$11.2M -$4.95M -$2.69M -119% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-12
Q4 2017 -$8.52M -$2.3M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-26
Q3 2017 -$2.08M Jul 1, 2017 Sep 30, 2017 10-K 2019-03-26
Q2 2017 -$1.88M Apr 1, 2017 Jun 30, 2017 10-K 2019-03-26
Q1 2017 -$2.26M Jan 1, 2017 Mar 31, 2017 10-K 2019-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.